Cargando…
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients
PURPOSE: Methotrexate administration is associated with frequent adverse neurological events during treatment for childhood acute lymphoblastic leukemia. Here, we present evidence to support the role of common drug interactions and low vitamin B(12) levels in potentiating methotrexate neurotoxicity....
Autores principales: | Forster, Victoria J., van Delft, Frederik W., Baird, Susan F., Mair, Shona, Skinner, Roderick, Halsey, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083755/ https://www.ncbi.nlm.nih.gov/pubmed/27659182 http://dx.doi.org/10.1007/s00280-016-3153-0 |
Ejemplares similares
-
Effect of methotrexate/vitamin B(12) on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity
por: Forster, Victoria J, et al.
Publicado: (2017) -
P389: METHOTREXATE NEUROTOXICITY IN ADULT ALL
por: Levavi, Hannah, et al.
Publicado: (2023) -
Methotrexate Neurotoxicity Is Related to Epigenetic Modification of the Myelination Process
por: Chen, Yu-Chieh, et al.
Publicado: (2021) -
Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017) -
Particulars of my life
por: Skinner, B. F. (Burrhus Frederic), 1904-1990
Publicado: (1977)